Licht, Daniella,Lovinger, Ioana,Guilatt, Laura Yehudit,Bassan, Merav
申请号：
AU2015209411
公开号：
AU2015209411A1
申请日:
2015.01.21
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The subject invention provides a modified release solid oral dosage form comprising a therapeutically effective amount of Pridopidine or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable rate controlling excipient, wherein the solid oral dosage form provides an in vivo plasma pridopidine concentration profile having a Mean C
